Protonix IV (pantoprazole), the first INTRAVENOUS proton pump inhibitor

Wyeth will soon market Protonix IV (pantoprazole), the first INTRAVENOUS proton pump inhibitor.

Until now, hospitalized patients who couldn't take an oral proton pump inhibitor had to get an intravenous H2-blocker.

Protonix IV is officially approved only for short-term treatment in GERD patients...but it will be used for other patients who can't take oral acid-suppressing drugs.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote